In vivo suppression of pancreatic tumour by targeting KRAS mutations using CANDDY technology

○Satoshi Imanishi, Lijuan Huang, Shoko Itakura, Megumi Saito, Megumi Tsukamoto, Masamichi Ishizaka, Tmohiro Yamaguchi, Yoichi Iwasaki, Etsuko Miyamoto-Sato

[1P-0419] In vivo suppression of pancreatic tumour by targeting KRAS mutations using CANDDY technology

○Satoshi Imanishi¹, Lijuan Huang¹, Shoko Itakura¹, Megumi Saito^1,3, Megumi Tsukamoto^1,3, Masamichi Ishizaka^1,3, Tmohiro Yamaguchi^1,3, Yoichi Iwasaki^1,3, Etsuko Miyamoto-Sato^1,2,3 (1.M-S. Mol. Med. Sci. Lab., Tokyo Univ. of Sci., 2.Res. Inst. for Biomed. Sci., Tokyo Univ. of Sci., 3.R&D Dep., FuturedMe Inc.)

chemical knockdown, protein degradation, undruggable, KRAS, CANDDY

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 43rd Annual Meeting of the Molecular Biology Society of Japan

[1P-0419] In vivo suppression of pancreatic tumour by targeting KRAS mutations using CANDDY technology

Password